The genome of a venomous caterpillar reveals that its pain-inducing venom peptides evolved from antimicrobial cecropin immune peptides through gene duplication and positive selection, with the original immune function progressively replaced by neuronal membrane-disrupting activity.
EC50: 190 nM (neurons) vs >100 µM (ancestor)Venom peptides Dv11/12 disrupt mammalian neuronal membranes over 500 times more potently than the ancestral cecropin-like peptide Dv13, demonstrating how evolution can dramatically shift peptide function.
What the researchers found
The near-chromosomal genome assembly of D. vulnerans identified 115 gene loci encoding polypeptide venom toxins, including multigene families and single-copy genes. A gene cluster on chromosome 7 encodes both pain-causing venom peptides and cecropin family antimicrobial peptides.
Key peptide characterization:
- Dv13 (trace component, cecropin-like): potently inhibited Gram-negative bacteria and fungi but only weakly permeabilized mammalian neuronal membranes (EC50 >100 µM)
- Dv11 and Dv12 (abundant in venom, sequence-divergent): potently disrupted mammalian neuronal membranes (EC50 as low as 190 nM — over 500-fold more potent than Dv13) but had reduced antimicrobial activity
Positive selection analysis confirmed strong evolutionary pressure driving the functional transition from immune defense to pain induction.
Why it matters
This study provides a rare, clear example of how new biological functions evolve from existing ones — immune peptides becoming venom toxins through gene duplication and adaptive mutation. For peptide science, it reveals the structural features that determine whether a peptide kills bacteria or disrupts nerve cells, providing valuable design principles for both antimicrobial drug development (what makes cecropins effective?) and pain research (what makes peptides neurotoxic?). The 500-fold difference in neuronal potency between closely related peptides is a striking structure-activity relationship.
How the study worked
Researchers generated a near-chromosomal-level genome assembly for D. vulnerans. Gene loci encoding venom toxins were identified through genomic and transcriptomic analysis. Evolutionary relationships between venom peptides and cecropin immune peptides were established through phylogenetic analysis and positive selection testing. Functional characterization included bacterial and fungal growth inhibition assays (antimicrobial activity), mammalian neuronal membrane permeabilization assays (pain-related activity), and EC50 determination for key peptides.
What this study cannot tell us
The functional characterization focused on three peptides (Dv11, Dv12, Dv13) from the 115 identified venom gene loci — the vast majority remain uncharacterized. The mammalian neuronal membrane assay measures permeabilization in vitro, which may not fully replicate the pain experience in intact organisms. The evolutionary pathway from immune peptide to toxin is inferred from sequence analysis and selection pressures, not directly observed. The study is in an insect (caterpillar) system, and the relevance of these specific peptides to human therapeutics requires further investigation.
How to read the evidence
This is a high-quality genomics and evolutionary biology study published in PNAS, combining a near-chromosomal genome assembly with quantitative bioactivity measurements and evolutionary analysis. The integration of genomic, phylogenetic, and functional data provides strong evidence for the evolutionary pathway described.
When this study was published
Published in 2025, this is a very recent study contributing to the rapidly growing field of venomics and evolutionary toxinology.
The bigger picture
Venom peptides are among the most potent bioactive molecules in nature and have already yielded important drugs — the pain medication ziconotide came from cone snail venom, and exenatide (for diabetes) came from Gila monster venom. This study adds caterpillar venom to the peptide pharmacology toolkit and, more fundamentally, reveals how nature engineers peptide function. Understanding the mutations that convert an antimicrobial peptide into a neurotoxin could inform the design of next-generation antimicrobial peptides that avoid neurotoxicity, or conversely, help develop new analgesic or anesthetic compounds.
Questions still open
- Could the structural differences between Dv13 (antimicrobial) and Dv11/12 (neurotoxic) be used to engineer safer antimicrobial peptides that avoid neuronal side effects?
- Are other insect venoms also derived from repurposed immune peptides, or is this unique to limacodid caterpillars?
- Could the potent neuronal membrane-disrupting activity of Dv11/12 be harnessed for developing local anesthetic or analgesic compounds?
Common questions
How did a caterpillar get venomous?
Why is it useful to study caterpillar venom?
Read the original research
Genome of venomous caterpillar Doratifera vulnerans reveals recruitment of immune peptides and their adaptation as pain-inducing toxins.
Proceedings of the National Academy of Sciences of the United States of America, 122(49), e2513640122
Citation
Goudarzi, Mohaddeseh H; Robinson, Samuel D; Cardoso, Fernanda C; Suryamohan, Kushal; Lawrence, Nicole; Eagles, David A; Hoang, Huy N; Vetter, Irina; Fairlie, David P; Seshagiri, Somasekar; King, Glenn F; Walker, Andrew A. (2025). Genome of venomous caterpillar Doratifera vulnerans reveals recruitment of immune peptides and their adaptation as pain-inducing toxins.. Proceedings of the National Academy of Sciences of the United States of America, 122(49), e2513640122. https://doi.org/10.1073/pnas.2513640122